Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Catalytica Inc. files for public offering of 2,250,000 shares of common stock.


MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Sept. 12, 1995-- Catalytica, Inc. (Nasdaq:CTAL CTAL Confederacion de Trabajadores de America Latina (Confederation of Latin American Workers)
CTAL Canadian Tire Acceptance Limited
CTAL Computer Technology Application Lab, Inc.
CTAL Confidentially Typed Assembly Language
) today announced that it has filed a registration statement with the Securities and Exchange Commission with respect to a proposed public offering of 2,250,000 shares of its Common Stock, all of which will be offered by the Company. Oppenheimer & Co., Inc. has been retained to assist in the placement of the securities to select institutional investors Institutional Investor

A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions.
.

The net proceeds Net Proceeds

The amount received after all costs are deducted from the sale of a piece of property or security.

Notes:
In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions).
 to the Company will be used for general corporate purposes, including working capital.

Catalytica is developing and offering to its customers advanced products that use the Company's proprietary catalytic technologies to yield economic and environmental benefits by lowering manufacturing costs and reducing hazardous byproducts.

Catalytica currently is focused on applying its technologies to two primary areas: improving production of pharmaceutical intermediates and developing advanced combustion systems to reduce toxic emissions generated by natural gas turbines.

A registration statement relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor any offer to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities in any State in which an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such State. Copies of the preliminary prospectus Preliminary Prospectus

A first draft registration statement filed by a firm prior to proceeding with an initial public offering of securities. The document, filed with the Securities & Exchange Commission, is intended to provide pertinent information to prospective shareholders
 relating to the offering may be obtained from Oppenheimer & Co., Inc., Oppenheimer Tower, World Financial Center, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
, New York 10281.

CONTACT: Catalytica, Inc.

Alice Galloway, 415/940-6382
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 12, 1995
Words:278
Previous Article:Solar-powered plane breaks world record.
Next Article:Vical initiates Allovectin-7 Phase II gene therapy trials.
Topics:



Related Articles
Fuisz Technologies files for secondary offering.
Catalytica announces intention to declare a dividend in the form of a warrant to purchase Common Stock.
Definitive agreement signed for Catalytica's purchase of Glaxo Wellcome's pharmaceutical plant in Greenville, N.C.
Catalytica Reports Third Quarter and Nine Months Results.
Catalytica Reports First Quarter Financial Results.
CombiChem, Inc. Announces Initial Public Offering of 2,250,000 Shares of Common Stock at $8.00 Per Share.
Catalytica Reports Second Quarter and First Half Financial Results.
Catalytica Reports Fourth Quarter and 1998 Financial Results.
Catalytica to Sell Pharmaceutical Operations to DSM and Spin-off Remaining Businesses to Stockholders.
Gramercy raises $80m through stock offering.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles